{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:20:55Z","timestamp":1785489655136,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jhin.2025.10.019","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:45:01Z","timestamp":1761810301000},"page":"211-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Colistin monotherapy versus colistin combination therapy in the treatment of patients with multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a meta-analysis"],"prefix":"10.1016","volume":"167","author":[{"given":"M.E.","family":"Falagas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.S.","family":"Kontogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sargianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.","family":"Bousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ntourakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2025.10.019_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jac\/dkx368","article-title":"Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis","volume":"73","author":"Kengkla","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2025.10.019_bib2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2025.10.019_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s40121-022-00597-w","article-title":"Carbapenem-resistant Acinetobacter baumannii: colonization, infection and current treatment options","volume":"11","author":"Bartal","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jhin.2025.10.019_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111367","article-title":"Carbapenem-resistant Acinetobacter baumannii raises global alarm for new antibiotic regimens","volume":"27","author":"Thacharodi","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.jhin.2025.10.019_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00284-022-03061-7","article-title":"Current treatment strategies against multidrug-resistant bacteria: a review","volume":"79","author":"Parmanik","year":"2022","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.jhin.2025.10.019_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00093-24","article-title":"The challenges of difficult-to-treat Acinetobacter infections","volume":"37","author":"Richards","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jhin.2025.10.019_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/pathogens14040307","article-title":"New \u03b2-lactam\/\u03b2-lactamase inhibitor combination antibiotics","volume":"14","author":"Sargianou","year":"2025","journal-title":"Pathogens"},{"key":"10.1016\/j.jhin.2025.10.019_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40265-024-02104-6","article-title":"Treatment approaches for carbapenem-resistant Acinetobacter baumannii infections","volume":"85","author":"Iovleva","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.jhin.2025.10.019_bib10","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s10096-014-2124-9","article-title":"Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review","volume":"33","author":"Poulikakos","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jhin.2025.10.019_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/dkw377","article-title":"Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis","volume":"72","author":"Zusman","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.jhin.2025.10.019_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11113239","article-title":"Colistin monotherapy versus colistin plus meropenem combination therapy for the treatment of multidrug-resistant Acinetobacter baumannii infection: a meta-analysis","volume":"11","author":"Huang","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhin.2025.10.019_bib13","article-title":"Colistin monotherapy versus combination therapy for carbapenem-resistant organisms","volume":"2","author":"Kaye","year":"2022","journal-title":"NEJM Evidence"},{"key":"10.1016\/j.jhin.2025.10.019_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","article-title":"Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial","volume":"18","author":"Paul","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhin.2025.10.019_bib15","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.21608\/ejhm.2023.305779","article-title":"Colistin versus colistin & meropenem in extensively resistant Enterobacterales organisms therapy in critically ill patients","volume":"92","author":"Saeed","year":"2023","journal-title":"Egypt J Hosp Med"},{"key":"10.1016\/j.jhin.2025.10.019_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/ijccm.IJCCM_302_17","article-title":"Colistin versus colistin combined with ampicillin\u2013sulbactam for multiresistant Acinetobacter baumannii ventilator-associated pneumonia treatment: an open-label prospective study","volume":"22","author":"Makris","year":"2018","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.jhin.2025.10.019_bib17","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1017\/S095026881200194X","article-title":"Colistin vs the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"141","author":"Aydemir","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jhin.2025.10.019_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/cit253","article-title":"Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial","volume":"57","author":"Durante-Mangoni","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2025.10.019_bib19","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1128\/AAC.02435-13","article-title":"Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections","volume":"58","author":"Sirijatuphat","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2025.10.019_bib20","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3390\/antibiotics11121707","article-title":"Colistin monotherapy versus colistin plus sitafloxacin for therapy of carbapenem-resistant Acinetobacter baumannii infections: a preliminary study","volume":"11","author":"Sirijatuphat","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.jhin.2025.10.019_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jgar.2018.11.016","article-title":"Colistin monotherapy versus colistin\/rifampicin combination therapy in pneumonia caused by colistin-resistant Acinetobacter baumannii: a randomised controlled trial","volume":"17","author":"Park","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jhin.2025.10.019_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmi.2017.09.016","article-title":"The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii","volume":"24","author":"Amat","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2025.10.019_bib23","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10096-014-2070-6","article-title":"Comparison of colistin\u2013carbapenem, colistin\u2013sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections","volume":"33","author":"Batirel","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jhin.2025.10.019_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijantimicag.2009.10.005","article-title":"Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2025.10.019_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4046\/trd.2009.67.3.212","article-title":"The comparative efficacy of colistin monotherapy and combination therapy based on in vitro antimicrobial synergy in ventilator-associated pneumonia caused by multi-drug resistant Acinetobacter baumannii","volume":"67","author":"Jang","year":"2016","journal-title":"Tuberc Resp Dis"},{"key":"10.1016\/j.jhin.2025.10.019_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s15010-013-0495-y","article-title":"Comparison of colistin and colistin\/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"42","author":"Kalin","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.jhin.2025.10.019_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7196\/SAJCC.2015.v31i2.246","article-title":"Comparison of the efficacy of colistin monotherapy and colistin combination therapies in the treatment of nosocomial pneumonia and ventilator-associated pneumonia caused by Acinetobacter baumannii","volume":"31","author":"Kara","year":"2015","journal-title":"S Afr J Crit Care"},{"key":"10.1016\/j.jhin.2025.10.019_bib28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijid.2020.05.100","article-title":"The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii","volume":"97","author":"Katip","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jhin.2025.10.019_bib29","doi-asserted-by":"crossref","first-page":"908.e1","DOI":"10.1016\/j.cmi.2017.10.033","article-title":"Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii","volume":"24","author":"Liang","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2025.10.019_bib30","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1177\/0300060519879336","article-title":"Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem","volume":"47","author":"Park","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jhin.2025.10.019_bib31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jgar.2021.01.018","article-title":"What is the optimal antibiotic treatment strategy for carbapenem-resistant Acinetobacter baumannii (CRAB)? A multicentre study in Korea","volume":"24","author":"Seok","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jhin.2025.10.019_bib32","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2147\/IDR.S234211","article-title":"Colistin plus carbapenem versus colistin monotherapy in the treatment of carbapenem-resistant Acinetobacter baumannii pneumonia","volume":"12","author":"Shi","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jhin.2025.10.019_bib33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/0255-0857.103767","article-title":"Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: monotherapy or combination therapy?","volume":"30","author":"\u015eim\u015fek","year":"2012","journal-title":"Ind J Med Microbiol"},{"key":"10.1016\/j.jhin.2025.10.019_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3855\/jidc.6195","article-title":"Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia","volume":"9","author":"Yilmaz","year":"2015","journal-title":"J Infect Dev Countries"},{"key":"10.1016\/j.jhin.2025.10.019_bib35","first-page":"ME05","article-title":"Burden of antibiotic resistance in common infectious diseases: role of antibiotic combination therapy","volume":"8","author":"Mehta","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jhin.2025.10.019_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1347750","article-title":"Combating antimicrobial resistance: the silent war","volume":"15","author":"Bo","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhin.2025.10.019_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1749-7922-9-39","article-title":"Cost of care and antibiotic prescribing attitudes for community-acquired complicated intra-abdominal infections in Italy: a retrospective study","volume":"9","author":"Dalfino","year":"2014","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.jhin.2025.10.019_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00912","article-title":"Efficacy of colistin and its combination with rifampin in vitro and in experimental models of infection caused by carbapenemase-producing clinical isolates of Klebsiella pneumoniae","volume":"9","author":"Pach\u00f3n-Ib\u00e1\u00f1ez","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jhin.2025.10.019_bib39","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1128\/AAC.00703-13","article-title":"Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"57","author":"Lee","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2025.10.019_bib40","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1469-0691.2008.02061.x","article-title":"Colistin monotherapy vs combination therapy: evidence from microbiological, animal and clinical studies","volume":"14","author":"Petrosillo","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2025.10.019_bib41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.cmi.2019.03.014","article-title":"Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment","volume":"25","author":"Piperaki","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2025.10.019_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2004.10.001","article-title":"Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria","volume":"25","author":"Li","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2025.10.019_bib43","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2025.10.019_bib44","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review","volume":"60","author":"Zavascki","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2025.10.019_bib45","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/cc3995","article-title":"Toxicity of polymyxins: a systematic review of the evidence from old and recent studies","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.jhin.2025.10.019_bib46","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/jac\/dkh369","article-title":"Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections","volume":"54","author":"Sobieszczyk","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2025.10.019_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106328","article-title":"Polymyxins for the treatment of lower respiratory tract infections: lessons learned from the integration of clinical pharmacokinetic studies and clinical outcomes","volume":"57","author":"Almangour","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2025.10.019_bib48","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1128\/AAC.00839-16","article-title":"In vitro synergistic activity of antimicrobial agents in combination against clinical isolates of colistin-resistant Acinetobacter baumannii","volume":"60","author":"Bae","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2025.10.019_bib49","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1590\/0037-8682-0081-2014","article-title":"Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii","volume":"47","author":"Liu","year":"2014","journal-title":"Rev Soc Bras Med Trop"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019567012500338X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019567012500338X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:30:43Z","timestamp":1768422643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019567012500338X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":48,"alternative-id":["S019567012500338X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2025.10.019","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colistin monotherapy versus colistin combination therapy in the treatment of patients with multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2025.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Healthcare Infection Society. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}